Vaxxinity Inc
(OTCPK:VAXX)
$
0.025
+0.025 (+25400%)
Market Cap: 3.23 Mil
Enterprise Value: 13,000.00
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 
Vaxxinity Inc at Bank of America Healthcare Conference Transcript
May 12, 2022 / 05:40PM GMT
Release Date Price:
$4.07
(+2.26%)
Geoff Meacham
Bank of America Merrill Lynch - Analyst
Okay. Welcome to the third day of the Bank of America healthcare conference. So my name is Geoff Meacham. I am the biopharma analyst here at BofA. And for those on the webcast, we have a great room here in person. So it's been an awesome experience to do face-to-face meetings finally.
But we are thrilled today to do a Q&A with Vaxxinity. And we have Mei Mei who is the Co-Founder, President, CEO, and Director. That's a lot of --
Mei Mei Hu
Vaxxinity, Inc. - Co-Founder, President, CEO, & Director
That's a mouthful.
Geoff Meacham
Bank of America Merrill Lynch - Analyst
Right.
Mei Mei Hu
Vaxxinity, Inc. - Co-Founder, President, CEO, & Director
Yeah.
Geoff Meacham;Mei Mei Hu
Bank of America Merrill Lynch - Analyst;Vaxxinity, Inc.
So do you want to give a quick overview, and then we can get in some -- lots of questions?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers